We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+29.1%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$976M
AUM Growth
+$65.1M
Cap. Flow
+$24.5M
Cap. Flow %
2.51%
Top 10 Hldgs %
37.09%
Holding
100
New
33
Increased
11
Reduced
19
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Miscellaneous 25.09%
3 Technology 18.45%
4 Industrials 16.44%
5 Consumer Discretionary 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAR icon
51
Darling Ingredients
DAR
$10.1B
$7.37M 0.76%
135,000
-55,000
-29% -$3.28M
DAL icon
52
Delta Air Lines
DAL
$52.7B
$7.21M 0.74%
+77,000
New +$5.81M
RUN icon
53
CALL
Sunrun
RUN
$2.11B
$6.69M 0.69%
+500,000
New +$6.75M
FLNC icon
54
PUT
Fluence Energy
FLNC
$1.56B
$5.96M 0.61%
+300,000
New +$5.58M
TAN icon
55
CALL
Invesco Solar ETF
TAN
$1.26B
$5.92M 0.61%
+100,000
New +$6.07M
CRDO icon
56
Credo Technology Group
CRDO
$43.7B
$5.85M 0.6%
21,500
-43,500
-67% -$8.6M
LION icon
57
Lionsgate Studios
LION
$3.39B
$5.74M 0.59%
+375,000
New +$4.85M
WELL icon
58
Welltower
WELL
$172B
$5.67M 0.58%
25,000
-25,000
-50% -$5.29M
ALDX icon
59
Aldeyra Therapeutics
ALDX
$89.9M
$5.65M 0.58%
2,652,315
+500,000
+23% +$860K
NVTS icon
60
PUT
Navitas Semiconductor
NVTS
$3B
$5.38M 0.55%
+300,000
New +$5.72M
KEYS icon
61
PUT
Keysight
KEYS
$54.5B
$5.25M 0.54%
+15,000
New +$5.12M
FFIV icon
62
F5
FFIV
$22.3B
$4.99M 0.51%
+12,000
New +$4.26M
IVA
63
Inventiva
IVA
$1.11B
$4.8M 0.49%
+1,270,000
New +$6.1M
ELDN icon
64
Eledon Pharmaceuticals
ELDN
$260M
$4.09M 0.42%
1,039,275
EWTX icon
65
PUT
Edgewise Therapeutics
EWTX
$4.64B
$4.06M 0.42%
+100,000
New +$3.45M
SHLS icon
66
CALL
Shoals Technologies Group
SHLS
$1.2B
$3.96M 0.41%
+400,000
New +$3.63M
COMP icon
67
CALL
Compass
COMP
$8.42B
$3.7M 0.38%
300,000
-100,000
-25% -$833K
WDC icon
68
CALL
Western Digital
WDC
$166B
$3.19M 0.33%
+5,000
New +$2.43M
COMP icon
69
Compass
COMP
$8.42B
$3.08M 0.32%
+250,000
New +$2.08M
CMPX icon
70
Compass Therapeutics
CMPX
$432M
$3.07M 0.31%
+1,400,000
New +$4.13M
NB
71
NioCorp Developments
NB
$601M
$2.17M 0.22%
450,000
SCYX icon
72
SCYNEXIS
SCYX
$53.6M
$1.01M 0.1%
247,811
JSPR icon
73
Jasper Therapeutics
JSPR
$23.3M
$569K 0.06%
1,352,106
NVNO
74
enVVeno Medical
NVNO
$7.47M
$387K 0.04%
36,166
ACHC icon
75
Acadia Healthcare
ACHC
$2.66B
-396,192
Closed -$9.27M

Similar funds

Kingdon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Kingdon Capital Management held 100 positions worth $976M, up 7.2% from $911M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kingdon Capital Management's Q2 2026 filing shows 33 new, 11 increased, 19 reduced and 26 closed positions. Its largest new stake was GRAIL Inc: 340,000 shares worth $23.2M. The largest sale was Soleno Therapeutics, an estimated $19.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Technology.

  • Kingdon Capital Management's largest Q2 2026 buy was GRAIL Inc: 340,000 shares worth $23.2M.
  • Kingdon Capital Management added most to NVIDIA in Q2 2026, an estimated $8.22M increase.
  • Kingdon Capital Management's biggest Q2 2026 reduction was Flex, cutting an estimated $10.3M.
  • Kingdon Capital Management fully exited Soleno Therapeutics in Q2 2026, selling an estimated $19.3M.
  • Kingdon Capital Management's ten largest holdings make up 37% of its $976M portfolio in Q2 2026.
  • Kingdon Capital Management opened 33 new positions and closed 26 in Q2 2026.
  • Kingdon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $976M.

Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.